The nationwide experiment will initially include around 100,000 volunteers.
Signaling pathways triggered by the mother’s immune system may cause complications during fetal development.
The Scientist
Most Recent
T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections.
A single receptor on natural killer cells recognizes an amino acid sequence conserved across Zika, dengue, and related pathogens.
Fotis Kafatos, a Greek researcher famous for his work on malaria, has died at age 77.
A team has engineered two stem cell lines into “synthetic T cells” that destroy breast cancer cells in vitro.
The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas.
At low doses, resveratrol enhanced human T-cell activity in vitro, while at high doses it interfered with cell signaling.
In mice, the tumor cells are able to thwart the immune response that would kill them—but immunotherapy prevented the return of melanoma.
Researchers find that about a quarter of the immune cells are replaced every year.
In addition to circulating in the blood as immune sentinels, macrophages play specialized roles in different organs around the body.
Popular Now
-
The Nutshell Estonia Offers Free Genetic Testing to Residents -
Daily News Human Brain Organoids Thrive in Mouse Brains After implantation, the tissue developed blood vessels and became integrated into neuronal networks in the animals’ brains.
-
Daily News RNA Injection Restores Hearing in Guinea Pigs Researchers deliver small interfering RNAs loaded into nanoparticles into the ears of adult guinea pigs to regenerate hair cells damaged by noise.
-
The Nutshell Jim Bridenstine Confirmed to Lead NASA The US Senate narrowly approved the politician, who does not have a science background.
Current Issue
© 1986-2018 The Scientist
